Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 2
1968 4
1969 3
1970 1
1971 2
1972 4
1973 10
1974 9
1975 7
1976 7
1977 8
1978 10
1979 12
1980 15
1981 15
1982 14
1983 26
1984 15
1985 14
1986 30
1987 25
1988 27
1989 37
1990 35
1991 34
1992 34
1993 39
1994 44
1995 55
1996 57
1997 50
1998 70
1999 72
2000 58
2001 59
2002 82
2003 83
2004 95
2005 101
2006 89
2007 118
2008 142
2009 148
2010 168
2011 155
2012 196
2013 218
2014 230
2015 244
2016 239
2017 263
2018 294
2019 282
2020 314
2021 285
2022 251
2023 229
2024 94

Text availability

Article attribute

Article type

Publication date

Search Results

4,561 results

Results by year

Filters applied: . Clear all
Page 1
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Cirino AL, Fox JC, Lakdawala NK, Ware JS, Caleshu CA, Helms AS, Colan SD, Girolami F, Cecchi F, Seidman CE, Sajeev G, Signorovitch J, Green EM, Olivotto I. Ho CY, et al. Circulation. 2018 Oct 2;138(14):1387-1398. doi: 10.1161/CIRCULATIONAHA.117.033200. Epub 2018 Aug 23. Circulation. 2018. PMID: 30297972 Free PMC article.
RESULTS: Median age of diagnosis was 45.8 [30.9-58.1] years and 37% of patients were female. Age of diagnosis and sarcomere mutation status were predictive of outcomes. Patients <40 years old at diagnosis had a 77% [95% confidence interval: 72%, 80%] cumulative incidenc …
RESULTS: Median age of diagnosis was 45.8 [30.9-58.1] years and 37% of patients were female. Age of diagnosis and sarcomere mutation status …
Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy.
Wang J, Wang Y, Zou Y, Sun K, Wang Z, Ding H, Yuan J, Wei W, Hou Q, Wang H, Liu X, Zhang H, Ji Y, Zhou X, Sharma RK, Wang D, Ahmad F, Hui R, Song L. Wang J, et al. Eur J Heart Fail. 2014 Sep;16(9):950-7. doi: 10.1002/ejhf.144. Epub 2014 Jul 31. Eur J Heart Fail. 2014. PMID: 25132132 Free article.
AIMS: Although genetic testing has been recommended in patients with hypertrophic cardiomyopathy (HCM) in current clinical practice, its utility in prognostic prediction remains to be ascertained. We assessed the dosage effect of rare variants in sarcomere genes on …
AIMS: Although genetic testing has been recommended in patients with hypertrophic cardiomyopathy (HCM) in current clinical practice, its uti …
Atrial Fibrillation in Hypertrophic Cardiomyopathy.
Vaidya K, Semsarian C, Chan KH. Vaidya K, et al. Heart Lung Circ. 2017 Sep;26(9):975-982. doi: 10.1016/j.hlc.2017.05.116. Epub 2017 May 23. Heart Lung Circ. 2017. PMID: 28602671 Review.
Hypertrophic cardiomyopathy.
Towbin JA. Towbin JA. Pacing Clin Electrophysiol. 2009 Jul;32 Suppl 2:S23-31. doi: 10.1111/j.1540-8159.2009.02381.x. Pacing Clin Electrophysiol. 2009. PMID: 19602159 Review.
Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
Adamczak DM, Oko-Sarnowska Z. Adamczak DM, et al. Cardiol Rev. 2018 May/Jun;26(3):145-151. doi: 10.1097/CRD.0000000000000184. Cardiol Rev. 2018. PMID: 29621050 Review.
The disease affects at least 0.2% of the population worldwide and is the most common cause of sudden cardiac death in young people and competitive athletes because of fatal ventricular arrhythmia. In some patients, however, HCM has a benign course. Therefore, it is of utmo …
The disease affects at least 0.2% of the population worldwide and is the most common cause of sudden cardiac death in young people and compe …
Apical hypertrophic cardiomyopathy: Present status.
Jan MF, Todaro MC, Oreto L, Tajik AJ. Jan MF, et al. Int J Cardiol. 2016 Nov 1;222:745-759. doi: 10.1016/j.ijcard.2016.07.154. Epub 2016 Jul 28. Int J Cardiol. 2016. PMID: 27521551 Review.
This review provides an overview of incidence, phenotypic expressions, clinical features, prognosis, and management of this heterogeneous clinical entity, which may play a more relevant role in the burden of sudden cardiac death than previously thought....
This review provides an overview of incidence, phenotypic expressions, clinical features, prognosis, and management of this heterogen …
What May the Future Hold for Sports Cardiology?
La Gerche A, Baggish A, Heidbuchel H, Levine BD, Rakhit D. La Gerche A, et al. Heart Lung Circ. 2018 Sep;27(9):1116-1120. doi: 10.1016/j.hlc.2018.05.193. Epub 2018 Jun 6. Heart Lung Circ. 2018. PMID: 29907457 Review.
Cardiomyopathy in pregnancy.
Lewey J, Haythe J. Lewey J, et al. Semin Perinatol. 2014 Aug;38(5):309-17. doi: 10.1053/j.semperi.2014.04.021. Epub 2014 Jun 5. Semin Perinatol. 2014. PMID: 25037522 Review.
New Developments in Hypertrophic Cardiomyopathy.
Cooper RM, Raphael CE, Liebregts M, Anavekar NS, Veselka J. Cooper RM, et al. Can J Cardiol. 2017 Oct;33(10):1254-1265. doi: 10.1016/j.cjca.2017.07.007. Epub 2017 Jul 20. Can J Cardiol. 2017. PMID: 28941606 Review.
Surgical myectomy remains a major part of treatment; a greater recognition of abnormalities of the mitral valve apparatus can allow improved surgical options. Myocardial perfusion abnormalities are known to predict adverse outcome in hypertrophic cardiomyopathy and we disc …
Surgical myectomy remains a major part of treatment; a greater recognition of abnormalities of the mitral valve apparatus can allow improved …
4,561 results